RVX-297

CAS No. 1044871-04-6

RVX-297 ( RVX297 )

Catalog No. M10223 CAS No. 1044871-04-6

RVX-297 is a novel orally active, BD2 selective, BET bromodomain inhibitor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 177 Get Quote
10MG 295 Get Quote
25MG 502 Get Quote
50MG 709 Get Quote
100MG 1008 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    RVX-297
  • Note
    Research use only, not for human use.
  • Brief Description
    RVX-297 is a novel orally active, BD2 selective, BET bromodomain inhibitor.
  • Description
    RVX-297 is a novel orally active, BD2 selective, BET bromodomain inhibitor with Alpha Screen IC50 of 0.08, 0.05 and 0.02 uM for BRD2 (BD2), BRD3 (BD2) and BRD4 (BD2), respectively; displays about 50-fold selectivity over BD1; suppresses inflammatory gene expression in multiple immune cell types in culture; reduces pro-inflammatory mediators assessed in splenic gene expression and serum proteins in LPS model of inflammation.
  • Synonyms
    RVX297
  • Pathway
    Chromatin/Epigenetic
  • Target
    Bromodomain
  • Recptor
    Bromodomain
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1044871-04-6
  • Formula Weight
    423.51
  • Molecular Formula
    C24H29N3O4
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    COC1=C(C(NC(C2=CC(C)=C(OCCN3CCCC3)C(C)=C2)=N4)=O)C4=CC(OC)=C1
  • Chemical Name
    2-(3,5-dimethyl-4-(2-(pyrrolidin-1-yl)ethoxy)phenyl)-5,7-dimethoxyquinazolin-4(3H)-one

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Kharenko OA, et al. Biochem Biophys Res Commun. 2016 Aug 12;477(1):62-7.
molnova catalog
related products
  • TPOP146

    A potent and selective CBP/p300 bromodomain inhibitor with Kd of 134 nM for CBP bromodomain.

  • GSK4027

    GSK4027 (GSK 4027, GSK-4027) is a potent, selective, cell-penetrant chemical probe of PCAF/GCN5 bromodomain with pKi of 8.9 for both.

  • BRD4 inhibitor Compo...

    BRD4 inhibitor Compound V is a domain-selective inhibitor of BRD4 with IC50 of 1.8 uM for BRD4 BD1, displays 6- and 16-fold selectivity for BRD4 over BRD2 and BRD3, respectively.